Amylyx Pharmaceuticals, Inc. - COM (AMLX)

Historical Portfolio Holders from Q1 2022 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
47.4 M
Holdings value Q1 2024
$135 M
Value change Q1 2024
-$233 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
135
Number of buys Q1 2024
79
Number of sells Q1 2024
-104
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.006%
CUSIP
03237H101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 47.4 M $135 M -$233 M $2.84 142
2023 Q4 57.5 M $846 M -$52.5 M $14.72 180
2023 Q3 58.9 M $1.08 B +$85.4 M $18.31 171
2023 Q2 54.5 M $1.17 B +$53.6 M $21.57 152
2023 Q1 51.4 M $1.51 B +$73.7 M $29.34 149
2022 Q4 48.5 M $1.79 B +$430 M $36.95 130
2022 Q3 36.6 M $1.03 B +$308 M $28.15 92
2022 Q2 26.4 M $509 M +$61.9 M $19.26 74
2022 Q1 23.3 M $299 M +$299 M $12.85 69